Jones Hill Capital LP
Source: SEC Form 13F · as of Mar 2026Jones Hill Capital LP holds 23 biotech & pharma companies tracked by BioSniper, totaling $425.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
23
Total value held
$425.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for BIOMARIN PHARMACEUTICAL INC (BMRN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| BMRNBIOMARIN PHARMACEUTICAL INC | 1,268,390 | $71.7M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 108,603 | $48.5M |
| PCVXVaxcyte, Inc. | 644,831 | $37.5M |
| NUVLNuvalent, Inc. | 300,830 | $30.8M |
| TERNTerns Pharmaceuticals, Inc. | 521,237 | $27.5M |
| BCAXBicara Therapeutics Inc. | 1,260,136 | $25.1M |
| ANIPANI PHARMACEUTICALS INC | 318,591 | $24.5M |
| RAREUltragenyx Pharmaceutical Inc. | 1,165,557 | $24.4M |
| ELVNEnliven Therapeutics, Inc. | 593,040 | $23.2M |
| AMLXAmylyx Pharmaceuticals, Inc. | 1,598,794 | $22.2M |
| ARGXARGENX SE | 25,995 | $19.0M |
| FULCFulcrum Therapeutics, Inc. | 1,771,926 | $13.6M |
| VIRVir Biotechnology, Inc. | 1,198,213 | $10.7M |
| NUVBNuvation Bio Inc. | 2,383,031 | $10.2M |
| ORKAOruka Therapeutics, Inc. | 140,843 | $6.9M |
| MANEVeradermics Incorporated | 100,843 | $6.4M |
| GPCRStructure Therapeutics Inc. | 100,593 | $4.8M |
| TRDAEntrada Therapeutics, Inc. | 374,010 | $4.7M |
| PHVSPharvaris N.V. | 167,014 | $4.7M |
| TRVITrevi Therapeutics, Inc. | 370,175 | $4.4M |
| RLMDRELMADA THERAPEUTICS, INC. | 342,752 | $2.4M |
| SLNSilence Therapeutics Plc | 301,604 | $1.6M |
| AVBPArriVent BioPharma, Inc. | 45,809 | $1.1M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.